About the 4th Cell Therapy Potency Assay Summit
Returning to Boston, the 4th Cell Therapy Potency Assay Summit introduces enhanced quality control content and a balanced focus across cell types and disease indications. This summit is crucial for staying ahead of the latest FDA regulatory updates and gaining insights from industry leaders who have dealt directly with regulatory bodies. Since its inception, the summit has been the go-to event for analytical, quality control, and regulatory experts to share development strategies and the latest technologies that may streamline your assay development workflows.
TAKE A PEEK AT THE COMPANIES ATTENDING
Don't Miss Out On...
Gaining insights from experts at BlueRock Therapeutics, Bristol Myers Squibb and Vertex Therapeutics on the latest advancements in potency assay development
Learning about the new FDA potency guidance and how to implement these requirements effectively in your development processes
Discovering cutting-edge technologies for assay quantification, including impedance assays and closed systems, to enhance accuracy
Participating in hands-on workshops focused on leveraging AI for potency assay development and overcoming commercialization challenges
Deep diving into quality control strategies with increased content on ensuring product consistency and reducing batch variability
Who Will You Meet?
“I liked the opportunity to meet with others in the area and to share our experiences. It’s an excellent venue for learning the latest and for networking”
~ Head of Analytical & Translational Sciences, Tigen Pharma, 2024 Speaker
“The selection of speakers and panelists were very knowledgeable, passionate and approachable. The event was very organized, from the timing of each talk, the breaks and the planned opportunities for networking”
~ Head of Assay Development, Kiromic Biopharma, 2024 Speaker